APO RESEARCH · REPORT
Artificial Pancreas Devices Systems
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Product & engineering
Understand the product.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Selected research
Industry Research
Artificial Pancreas Devices Systems Industry Research Report 2026
Market perspective
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
Read the full market overview
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Scope
This report quantifies the global Artificial Pancreas Devices Systems market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Pancreas Devices Systems Market by Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Artificial Pancreas Devices Systems Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Artificial Pancreas Devices Systems Segment by Application
Hospitals
Clinics
Artificial Pancreas Devices Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artificial Pancreas Devices Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artificial Pancreas Devices Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Threshold Suspended Device Systems
- Hybrid Closed-loop APDS
- Other Systems
Applications
- Hospitals
- Clinics
Companies covered
- Medtronic
- Bigfoot Biomedical
- Beta Bionics
- Admetsys
- Insulet
- Tandem Diabetes Care
- Defymed
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Artificial Pancreas Devices Systems Market Size (2021-2032)
- 2.2.2 Global Artificial Pancreas Devices Systems Sales (2021-2032)
- 2.2.3 Global Artificial Pancreas Devices Systems Market Average Price (2021-2032)
- 2.3 Artificial Pancreas Devices Systems by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Threshold Suspended Device Systems
- 2.3.3 Hybrid Closed-loop APDS
- 2.3.4 Other Systems
- 2.4 Artificial Pancreas Devices Systems by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artificial Pancreas Devices Systems Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Artificial Pancreas Devices Systems Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Artificial Pancreas Devices Systems Revenue of Manufacturers (2021-2026)
- 3.4 Global Artificial Pancreas Devices Systems Average Price by Manufacturers (2021-2026)
- 3.5 Global Artificial Pancreas Devices Systems Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Artificial Pancreas Devices Systems, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Artificial Pancreas Devices Systems, Product Type & Application
- 3.8 Global Manufacturers of Artificial Pancreas Devices Systems, Established Date
- 3.9 Global Artificial Pancreas Devices Systems Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Bigfoot Biomedical
- 4.2.1 Bigfoot Biomedical Company Information
- 4.2.2 Bigfoot Biomedical Business Overview
- 4.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
- 4.2.5 Bigfoot Biomedical Recent Developments
- 4.3 Beta Bionics
- 4.3.1 Beta Bionics Company Information
- 4.3.2 Beta Bionics Business Overview
- 4.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
- 4.3.5 Beta Bionics Recent Developments
- 4.4 Admetsys
- 4.4.1 Admetsys Company Information
- 4.4.2 Admetsys Business Overview
- 4.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
- 4.4.5 Admetsys Recent Developments
- 4.5 Insulet
- 4.5.1 Insulet Company Information
- 4.5.2 Insulet Business Overview
- 4.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
- 4.5.5 Insulet Recent Developments
- 4.6 Tandem Diabetes Care
- 4.6.1 Tandem Diabetes Care Company Information
- 4.6.2 Tandem Diabetes Care Business Overview
- 4.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
- 4.6.5 Tandem Diabetes Care Recent Developments
- 4.7 Defymed
- 4.7.1 Defymed Company Information
- 4.7.2 Defymed Business Overview
- 4.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
- 4.7.5 Defymed Recent Developments
5 Global Artificial Pancreas Devices Systems Market Scenario by Region
- 5.1 Global Artificial Pancreas Devices Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artificial Pancreas Devices Systems Sales by Region: 2021-2032
- 5.2.1 Global Artificial Pancreas Devices Systems Sales by Region: 2021-2026
- 5.2.2 Global Artificial Pancreas Devices Systems Sales by Region: 2027-2032
- 5.3 Global Artificial Pancreas Devices Systems Revenue by Region: 2021-2032
- 5.3.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2021-2026
- 5.3.2 Global Artificial Pancreas Devices Systems Revenue by Region: 2027-2032
- 5.4 North America Artificial Pancreas Devices Systems Market Facts & Figures by Country
- 5.4.1 North America Artificial Pancreas Devices Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 5.4.3 North America Artificial Pancreas Devices Systems Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Artificial Pancreas Devices Systems Market Facts & Figures by Country
- 5.5.1 Europe Artificial Pancreas Devices Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 5.5.3 Europe Artificial Pancreas Devices Systems Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Artificial Pancreas Devices Systems Market Facts & Figures by Country
- 5.6.1 Asia Pacific Artificial Pancreas Devices Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Artificial Pancreas Devices Systems Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Artificial Pancreas Devices Systems Market Facts & Figures by Country
- 5.7.1 South America Artificial Pancreas Devices Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 5.7.3 South America Artificial Pancreas Devices Systems Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Artificial Pancreas Devices Systems Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Artificial Pancreas Devices Systems Sales by Type (2021-2032)
- 6.1.1 Global Artificial Pancreas Devices Systems Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2021-2032)
- 6.2 Global Artificial Pancreas Devices Systems Revenue by Type (2021-2032)
- 6.2.1 Global Artificial Pancreas Devices Systems Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2021-2032)
- 6.3 Global Artificial Pancreas Devices Systems Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Artificial Pancreas Devices Systems Sales by Application (2021-2032)
- 7.1.1 Global Artificial Pancreas Devices Systems Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2021-2032)
- 7.2 Global Artificial Pancreas Devices Systems Revenue by Application (2021-2032)
- 7.2.1 Global Artificial Pancreas Devices Systems Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2021-2032)
- 7.3 Global Artificial Pancreas Devices Systems Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Artificial Pancreas Devices Systems Value Chain Analysis
- 8.1.1 Artificial Pancreas Devices Systems Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Artificial Pancreas Devices Systems Production Mode & Process
- 8.2 Artificial Pancreas Devices Systems Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Artificial Pancreas Devices Systems Distributors
- 8.2.3 Artificial Pancreas Devices Systems Customers
9 Global Artificial Pancreas Devices Systems Analyzing Market Dynamics
- 9.1 Artificial Pancreas Devices Systems Industry Trends
- 9.2 Artificial Pancreas Devices Systems Industry Drivers
- 9.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
- 9.4 Artificial Pancreas Devices Systems Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst